PKBSM6556DJTO

human beta cell line

DMEM containing 5.6 mmol/L glucose, 2% BSA fraction V, fatty acid free, 50 μmol/L 2-mercaptoethanol, 10 mmol/L nicotinamide, 5.5 μg/mL transferrin, 6.7 ng/mL selenite, 100U/mL penicillin + 100 μg/mL streptomycin

EndoC-bH1

released

PKBSM3533XIDS

human beta cell line

DMEM LG (glucose 1 g/l), BSA fraction V (2% wt/vol), β-mercaptoethanol (50 μM), nicotinamide (10 mM), transferrin (5.5 μg/ml), sodium selenite (6.7 ng/ml), and penicillin–streptomycin (1%).

EndoC-bH1

released

PKBSM9187LZBV

human beta cell line

DMEM low glucose supplemented with 2% bovine serum albumin (BSA), 50 μM β-mercaptoethanol, 1% GlutaxMAX, 10 mM nicotinamide, 5.5 μg/mL human transferrin, and 6.7 ng/mL sodium selenite

EndoC-bH1

released

PKBSM2973NJDC

human beta cell line

Dulbecco’s modified Eagle medium with 5.6 mM glucose, 2% fatty acid–free BSA fraction V, 50 μM 2-mercaptoethanol, 10 mM nicotinamide, transferrin, selenite (6.7 ng/ml), and penicillin (100 U/ml) + streptomycin (100 μg/ml)

EndoC-bH1

released

PKBSM6845SNYE

human beta cell line

DMEM low glucose (1g/L), 2% Albumin from bovine serum fraction V, 50μM 2-mercaptoethanol, 10mM nicotinamide, 5.5 μg/mL transferrin, 6.7 ng/mL sodium selenite and Penicillin (100 units/mL)/Streptomycin (100 μg/mL)

EndoC-bH2

released

PKBSM0561GQKP

human beta cell line

DMEM low glucose (1 g/L) supplemented with 2% fatty acid free BSA , 10 mM nicotinamide, 5.5 µg/mL human transferrin, 6.7 ng/mL sodium selenite, 50 µM β-mercaptoethanol, 100 U/mL penicillin and 100 µg/mL streptomycin

EndoC-bH3

released

PKBSM5212UTHG

human beta cell line

DMEM containing 5.6 mmol/L glucose, 2% BSA fraction V, fatty acid free, 50 μmol/L 2-mercaptoethanol, 10 mmol/L nicotinamide, 5.5 μg/mL transferrin, 6.7 ng/mL selenite, 100U/mL penicillin + 100 μg/mL streptomycin

EndoC-bH1

released

PKBSM6750EOBQ

human beta cell line

DMEM that contained 5.6 mM glucose, 2% BSA fraction V, 50 μM 2-mercaptoethanol, 10 mM nicotinamide, 5.5 μg/ml transferrin, 6.7 ng/ml selenite, 100 U/ml penicillin, and 100 μg/ml streptomycin

EndoC-bH1

released

PKBSM5416TOEI

human beta cell line

DMEM (glucose 1 g/L), BSA fraction V (2% wt/vol), 2-mercaptoethanol (50 μM), nicotinamide (10 mM), transferrin (5.5 μg/mL), sodium selenite (6.7 ng/mL), PS (1%)

EndoC-bH1

released

PKBSM0734OIDU

human beta cell line

DMEM containing 5.6 mM glucose, 2% BSA fraction V , 10 mM nicotinamide, 50 μM 2-mercaptoethanol, 5.5 μg/mL transferrin, 6.7 ng/mL sodium selenite, 100 U/mL penicillin, and 100 μg/mL streptomycin

EndoC-bH1

released

PKBSM8133OGIJ

human beta cell line

DMEM containing 5.6 mmol/L glucose, 2% BSA fraction V, 50 μmol/L 2-mercaptoethanol, 10 mmol/L nicotinamide, 5.5 μg/mL transferrin, 6.7 ng/mL selenite, 100 units/mL penicillin, and 100 μg/mL streptomycin

EndoC-bH1

released

PKBSM8660JQFD

human beta cell line

DMEM that contained 5.6 mM glucose, 2% BSA fraction V , 50 μM 2-mercaptoethanol, 10 mM nicotinamide, 5.5 μg/ml transferrin, 6.7 ng/ml selenite, 100 U/ml penicillin, and 100 μg/ml streptomycin

EndoC-bH1

released

PKBSM6207TNSY

human beta cell line

DMEM that contained 5.6 mM glucose, 2% BSA fraction V, 50 μM 2-mercaptoethanol, 10 mM nicotinamide, 5.5 μg/ml transferrin, 6.7 ng/ml selenite, 100 U/ml penicillin, and 100 μg/ml streptomycin

EndoC-bH1

released

PKBSM2550NVQO

human beta cell line

low-glucose DMEM medium (5.6 mmol/L) supplemented with 2% BSA fraction V , 50 μM β-mercaptoethanol, 10 mM nicotinamide, 5.5 μg/mL human transferrin, 6.7 ng/mL selenite, 100 U/mL penicillin and 100 μg/mL streptomycin

EndoC-bH1

released

PKBSM4462KSYC

human beta cell line

DMEM that contained 5.6 mM glucose, 2% BSA fraction V, 50 μM 2-mercaptoethanol, 10 mM nicotinamide, 5.5 μg/ml transferrin, 6.7 ng/ml selenite, 100 U/ml penicillin, and 100 μg/ml streptomycin

EndoC-bH1

released

PKBSM8514OGUP

human beta cell line

Advanced DMEM/F12 supplemented with 2% fatty acid-free Bovine Serum Albumin Fraction V, 6.7 ng/mL sodium selenite, 50 μM 2-mercaptoethanol, 5.5 μg/mL human transferrin, 10 mM nicotinamide, 1% GlutaMAX and 100 U/mL Penicillin-Streptomycin

EndoC-bH3

released

PKBSM2497EGUQ

human beta cell line

Dulbecco’s modified Eagle’s medium containing 1g/L glucose (DMEM) supplemented with 2% BSA fraction V fatty acid free, 50 μM 2-mercaptoethanol, 10 mM nicotinamide, 5.5 μg/ml transferrin, 6.7 ng/ml selenite, 100 U/ml penicillin, and 100 μg/ml streptomycin

EndoC-bH1

released

PKBSM9444BMDZ

human beta cell line

CMRL-1066 medium supplemented with 10% FBS and 1% penicillin streptomycin

EndoC-Bh1

released

PKBSM6804KICF

human beta cell line

Dulbecco’s modified Eagle’s medium containing 1g/L glucose (DMEM) supplemented with 2% BSA fraction V fatty acid free, 50 μM 2-mercaptoethanol, 10 mM nicotinamide, 5.5 μg/ml transferrin, 6.7 ng/ml selenite, 100 U/ml penicillin, and 100 μg/ml streptomycin

EndoC-bH1

released

PKBSM9024KLYK

human beta cell line

low-glucose DMEM medium (5.6 mmol/L) supplemented with 2% BSA fraction V , 50 μM β-mercaptoethanol, 10 mM nicotinamide, 5.5 μg/mL human transferrin, 6.7 ng/mL selenite, 100 U/mL penicillin and 100 μg/mL streptomycin

EndoC-bH1

released

PKBSM2542NXUU

human beta cell line

Dulbecco’s modified Eagle medium with 5.6 mM glucose, 2% fatty acid–free BSA fraction V, 50 μM 2-mercaptoethanol, 10 mM nicotinamide, transferrin, selenite (6.7 ng/ml), and penicillin (100 U/ml) + streptomycin (100 μg/ml)

EndoC-bH1

released

PKBSM3112HPHH

human beta cell line

DMEM low glucose (1g/L), 2% Albumin from bovine serum fraction V, 50μM 2-mercaptoethanol, 10mM nicotinamide, 5.5 μg/mL transferrin, 6.7 ng/mL sodium selenite and Penicillin (100 units/mL)/Streptomycin (100 μg/mL)

EndoC-bH2

released

PKBSM6822XTNL

human beta cell line

DMEM containing 5.6 mmol/L glucose, 2% BSA fraction V, 50 μmol/L 2-mercaptoethanol, 10 mmol/L nicotinamide, 5.5 μg/mL transferrin, 6.7 ng/mL selenite, 100 units/mL penicillin, and 100 μg/mL streptomycin

EndoC-bH1

released

PKBSM3992LBEW

human beta cell line

DMEM medium (no other details provided)

EndoC-bH1

released

PKBSM1534PVXT

human beta cell line

Dulbecco's modified Eagle's medium (5,6 mmol/l) supplemented with 2% bovine serum albumin (BSA) fraction V , 50 μmol/L 2-β-mercaptoethanol, 10 mmol/L nicotinamide, 5.5 μg/ml transferrin, 6.7 ng/ml sodium selenite, 100 units/ml penicillin, and 100 μg/ml streptomycin

EndoC-bH1

released